We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Single-center report suggests cord blood transplant with abatacept improves outcomes in TP53-mutated AML, indicating a potential treatment advance.
No takes yet. Share an insight, caveat, or question.
Yasuda et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: